We Look Forward to Meeting You at DOT in Boston

Join us at Booth #312 to learn about exciting new drug discovery topics for products and services! 

  • Find an assay for your target with over 10,000 cell-based assays for in vitro pharmacology
  • Characterize compounds or biologics with binding and functional assays
  • Choose off-the-shelf products or screening services that meet your project need
  • Experience best-in-class offerings of 6 premier CROs: Cerep, DiscoverX, EMD Millipore Drug Discovery, Panlabs, Selcia Drug Discovery, and Villapharma

Presentations

September 18 at 9:05 am, Immuno-Oncology Track

Robust and Reproducible Target Biology-Based Bioassays for Characterization and Potency Measurement of Biologics Targeting Checkpoint Modulators
Presented by Alpana Prasad, Ph.D.

September 19 at 12:35 pm, Kinase Inhibitory Discovery Track

Use of InCELL Pulse™ Cellular Thermal Shift Target Engagement Assays in Early Drug Discovery
Presented by Paul Shapiro, Ph.D.
*Lunch Provided*



View Our Posters

Immuno-Oncology
Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors

CRISPR/PROTACs
Biosensor Development Using CRISPR to Quantify Endogenous Protein Expression Modulated by PROTACs

GPCRs

  • GPRC Allosteric Modulation: Another Shot on Goal
  • Improving Valvulopathy Prediction by Qualifying 5-HT2B Functional Assay Technologies
  • Validation of a Label-Free Mass
    Spectrometry-Based Binding Assay for the Gamma-Aminobutyric Acid B 1b Receptor
  • Real-Time Kinetic Analysis of GPCR Signaling in Stable PathHunter® Cell Lines (Presented by Montana Molecular)

 

Dig deep into your options at Booth #312 or online: 

Products: Eurofins DiscoverX
Services: Eurofins Discovery Services